Acebrophylline, Fexofenadine, and Levocetirizine Tablets combine three powerful ingredients to help manage respiratory and allergy-related conditions. This medicine is designed to ease breathing problems caused by asthma or chronic obstructive pulmonary disease (COPD) while also providing relief from allergy symptoms like sneezing, runny nose, and itchy eyes. Its unique combination works effectively to relax airway muscles, reduce inflammation, and block allergy triggers.

Take this medicine exactly as prescribed by your doctor. Usually, one tablet is taken once or twice a day with water, preferably after meals to avoid stomach discomfort. Swallow the tablet whole without crushing or chewing it. It is best to take the medicine at the same time every day to maintain a consistent level in your body. Never exceed the recommended dose, as it can lead to unwanted side effects.

Uses of Acebrophylline, Fexofenadine, and Levocetirizine Tablets

Here are the uses of Fexofenadine, Acebrophylline, and Levocetirizine Tablets: 

Treats Asthma and COPD: Acebrophylline, Fexofenadine, and Levocetirizine Tablets help to open airways and make breathing easier.

Reduces Allergy Symptoms: This tablet also relieves sneezing, runny nose, and itchy or watery eyes.

Minimizes Swelling and Inflammation: Calms down irritation in the airways and nasal passages.

Improves Sleep Quality: It also improves sleep quality by reducing nighttime coughing and breathing difficulties.

Possible Side Effects of Acebrophylline, Fexofenadine, and Levocetirizine Tablets

Like any medicine, these tablets may cause side effects in some people. Common side effects include:

• Drowsiness or feeling sleepy
• Dry mouth or throat
• Mild stomach upset
• Headache
• Dizziness or lightheadedness

Note: In rare cases, more serious side effects like difficulty breathing, chest pain, or severe allergic reactions can occur. If you notice any unusual symptoms, contact your doctor immediately. Most side effects are mild and go away as your body adjusts to the medication.